CRVL - CorVel Corp Market Capitalization-to-Revenue Ratio

Corporate company logo of CorVel Healthcare (CRVL)

CorVel Corporation relies on the US domestic market, meaning geopolitics only impacts the business through general cost inflation. The revenue multiple trend visualizes the efficiency of AI implementation for invoice automation, where 4.30 describes the current status of the metric. The stability of the server infrastructure and scheduled data center updates eliminate disruptions, guaranteeing reliable processing of insurance data.

CRVL CorVel Healthcare: Price-to-Revenue Ratio in the range 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for CorVel Healthcare (CRVL)

- current price and projected stock value:
- market capitalization statistics:
Fundamental company analysis:CRVL - CorVel Corp
Finished products of CorVel Corp

The P/S ratio compares market capitalization to annual sales volume, demonstrating the premium investors are willing to pay for each unit of revenue amid inflationary pressures. For CorVel Corporation (CRVL), this metric reflects market expectations regarding the implementation of AI platforms and telemedicine, where the current P/S level serves as an indicator of market confidence in a radical reduction of insurance costs through technological modernization.

Competitors of CorVel Corporation

VEEV (Veeva Systems) - Market Capitalization-to-Revenue Ratio|Doximity - Market Cap to Revenue|Price-to-Revenue Multiple HealthEquity, Inc.|Waystar Holding Corp. - P/S Multiple|Market Capitalization-to-Revenue Ratio PRVA (Privia Health Group)|Huron Consulting (HURN) - Price-to-Revenue Ratio|CERT - Price-to-Revenue Coefficient|OMCL (Omnicell Health) - P/S Multiple|Price-to-Revenue Ratio GDRX|Price-to-Revenue Ratio Schrodinger, Inc. (SDGR)|Market Cap to Revenue Phreesia PHR|P/S Multiple OMDA (Omada Health)|Market Cap to Sales Volume EVH (Evolent Health)|HSTM: Market Cap to Revenue|DH: Price-to-Revenue Ratio|CCSI (Consensus Corp) - Market Cap to Revenue|Price-to-Revenue Multiple agilonhealth.com AGL|ABSI (Absci Corp.) - P/S Multiple|SY (So-Young International Inc.) - Market Cap to Sales Volume|P/S Multiple NRC|Spok Corp - Market Cap to Revenue Ratio|Price-to-Revenue Ratio OptimizeRx Corporation OPRX|Market Capitalization-to-Revenue Ratio TBRG|SLP - Price-to-Revenue Ratio|SOPH - P/S Multiple|HCAT: P/S Multiple|CCLD - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Research Solutions Inc.|Price-to-Revenue Ratio DLHC|Price-to-Revenue Ratio OneMedNet Corp. (ONMD)|Scienture - Market Cap to Revenue Ratio|Healthcare Triangle, Inc. - Market Cap to Revenue|ISPC - Market Cap to Revenue|BFRG - Price-to-Revenue Ratio|Price-to-Revenue Coefficient SCWorx Corp. WORX|MSP Recovery Inc. (MSPR) - Price-to-Revenue Ratio|iCoreConnect Corp - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue MEDS|Price to Sales Orgenesis Corporation ORGS|P/S Multiple RCM|SHCR (Sharecare, Inc.) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Streamline Health Solutions, Inc. STRM|SYRA: Market Cap to Revenue Ratio|Apollo Medical Holdings Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio MODN (Model N Corporation)|NextGen Healthcare, Inc. (NXGN) - Price-to-Revenue Ratio